FDA warns of another compounding pharmacy recall
The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients.
The FDA says Clinical Specialties of Martinez, Ga., has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder in seniors.
The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since Dec. 18, the FDA said in an online posting.
Avastin is approved as a cancer drug, but it is structurally similar to Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors who prescribe it off-label, or without FDA approval. Repackaged injections of Avastin cost about $50, compared with $1,950 for Lucentis.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)